Translational research is an approach that aims to make medical research findings usable and applicable to patients without delay. It involves integration of different types of medical research. One of the aims of translational research is to deliver personalised medicine, in other words, giving the right treatment, to the right patient, at the right time.
Translational research can be:
Over half our clinical trials at the CTC have a T1 approach. Where possible and appropriate, they include an option for patients to consent to their biological samples (such as tissue and blood) being used in research, which may include:
Biomarkers from biospecimens may be studied for their potential utility, for example, as a diagnostic test for a disease, as prognostic markers or as markers that predict treatment response or toxicities. This information may be used to assess the eligibility of patients for new trials.
Biospecimens may be stored in biobanks for the future. Scientific knowledge and technology are developing rapidly, and research ideas may come about during the course of a trial running over several years.
Experiments on biospecimens are conducted at the laboratories of our research collaborators.
Translational research in cardiovascular trials
Translational research in oncology trials
Personalised medicine
Biobanking
Sydney Catalyst